Patent Assignment
Reel/Frame 074223/0753
Security Interest
Recorded: 2026-03-30
Pages: 10
Assignors
BAUSCH HEALTH IRELAND LIMITED
Executed: 2026-03-20
MEDICIS PHARMACEUTICAL CORPORATION
Executed: 2026-03-20
SALIX PHARMACEUTICALS, INC.
Executed: 2026-03-20
SOLTA MEDICAL IRELAND LIMITED
Executed: 2026-03-20
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, FLOOR 7E, ATTN: CORPORATE TRUST ADMINISTRATION, NEW YORK, NEW YORK, 10286
Covered Properties
(30)
Targeted Release Rifaximin Compositions
Application:
19/402,293 →
Publication:
US US20260076899A1
Topical Compositions
Treatment of Alcoholic Hepatitis
Application:
17/765,202 →
Publication:
US US20220378802A1
Crystalline and Liquid Crystalline 25-Hydroxy-Cholest-5-En-3-Sulfate Sodium and Methods for Preparing Same
Treatment of Non-Alcoholic Steatohepatitis (Nash)
Application:
17/924,101 →
Publication:
US US20230181601A1
Treatment of Non-Alcoholic Steatohepatitis (Nash)
Application:
17/924,103 →
Publication:
US US20230181602A1
Use of Oxygenated Cholesterol Sulfates for Treating at Least One of Insulin Resistance, Diabetes, and Prediabetes
25-Hydroxy-Cholest-5-En-3-Sulfate Choline and Methods for Preparing, and Uses of, Same
Application:
18/572,715 →
Publication:
US US20240425545A1
Salts Including Crystalline Salts of 25-Hydroxy-Cholest-5-En-3-Sulfate and Methods for Preparing Same
Application:
19/142,096 →
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Application:
18/115,286 →
Publication:
US US20230310458A1
25-Hydroxy-Cholest-5-En-3-Sulfate Choline, Formulations Thereof and Methods for Preparing, and Uses of Same
Application:
19/142,082 →
Publication:
US US20260207628A1
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide
Application:
19/011,381 →
Publication:
US US20250249021A1
Sustained Release Drug Delivery Systems and Related Methods
Application:
19/334,386 →
Publication:
US US20260137670A1
Treatment of Alcoholic Hepatitis
Application:
19/364,999 →
Publication:
US US20260102410A1
Solid Dispersion Forms of Rifaximin
Application:
19/299,563 →
Publication:
US US20250367175A1
Controlled delivery system
Depot Formulations
Injectable Controlled Release Composition Comprising High Viscosity Liquid Carrier
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Sucrose Acetate Isobutyrate Compositions with Low Peroxide Content
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
Uses of Oxygenated Cholesterol Sulfates (Ocs)
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof and at Least One Cyclic Oligosaccharide
Sustained Release Drug Delivery Systems with Reduced Impurities and Related Methods
Sustained Release Drug Delivery Systems and Related Methods
Sustained Release Drug Delivery Systems with Reduced Impurities and Related Methods
Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof and at Least One Cyclic Oligosaccharide
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2015
From: WRIGHT, JEREMY C; THEEUWES, FELIX; GIBSON, JOHN W; BRANHAM, KEITH E
To: DURECT CORPORATION
Reel/Frame 036962/0478 →
Assignment of Assignor's Interest
Nov 4, 2015
From: WRIGHT, JEREMY; TAMRAZ, WILMA; LEONARD, JOHN J; GIBSON, JOHN W
To: DURECT CORPORATION
Reel/Frame 036957/0842 →
Assignment of Assignor's Interest
Jun 21, 2016
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 038971/0172 →
Assignment of Assignor's Interest
Jan 4, 2017
From: ZOOGENIX
To: DURECT CORPORATION
Reel/Frame 040847/0001 →
Assignment of Assignor's Interest
Feb 6, 2017
From: WRIGHT, JEREMY; THEEUWES, FELIX; GIBSON, JOHN W; BRANHAM, KEITH
To: DURECT CORPORATION
Reel/Frame 041185/0366 →
Assignment of Assignor's Interest
Jul 30, 2019
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 049906/0155 →
Assignment of Assignor's Interest
May 23, 2022
From: LEE, MIN L.; MIKSZTAL, ANDREW R.
To: DURECT CORPORATION
Reel/Frame 059990/0067 →
Assignment of Assignor's Interest
Oct 25, 2022
From: LIN, WEIQI; BROWN, JAMES E.; BLASCHKE, TERRENCE
To: DURECT CORPORATION
Reel/Frame 061530/0639 →
Assignment of Assignor's Interest
Jan 9, 2023
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS; VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 062318/0868 →
Assignment of Assignor's Interest
Jun 27, 2023
From: REN, SHUNLIN; THEEUWES, FELIX; BROWN, JAMES E.; LIN, WEIQI
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 064083/0530 →
Assignment of Assignor's Interest
Jul 12, 2024
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS; VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 067982/0142 →
Assignment of Assignor's Interest
Sep 5, 2025
From: REN, SHUNLIN; XU, LEYUAN; NING, YANXIA; KIM, JIN KOUNG
To: VIRGINIA COMMONWEALTH UNIVERSITY; DURECT CORPORATION
Reel/Frame 072172/0272 →
Assignment of Assignor's Interest
Sep 5, 2025
From: VIRGINIA COMMONWEALTH UNIVERSITY
To: VIRGINIA COMMONWEALTH UNIVERSITY; THE UNITED STATESGOVERNMENTAS REPRESENTEDBY THEDEPARTMENTOFVETERANS AFFAIRS
Reel/Frame 072172/0570 →
Security Interest
Oct 7, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 072495/0656 →
Assignment of Assignor's Interest
Nov 20, 2025
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 072971/0589 →
Assignment of Assignor's Interest
Nov 20, 2025
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 072971/0624 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →
U.S. Patent Security Agreement Supplement
Nov 25, 2025
From: SALIX PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0409 →
Merger
Feb 19, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073837/0231 →
Merger
Feb 25, 2026
From: DURECT CORPORATION
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 073889/0196 →
Security Interest
Mar 30, 2026
From: MEDICIS PHARMACEUTICAL CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0509 →
Security Interest
Mar 30, 2026
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 074227/0537 →
Assignment of Assignor's Interest
Aug 14, 2026
From: LIN, WEIQI; MIKSZTAL, ANDREW R.
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 075655/0258 →
Assignment of Assignor's Interest
Aug 14, 2026
From: SARD, HOWARD
To: MEDICIS PHARMACEUTICAL CORPORATION
Reel/Frame 075654/0959 →
Assignment of Assignor's Interest
Aug 14, 2026
From: MORENCY, CYNTHIA A.; GONALEZ, MARIO
To: ORGANIX CHEMISTRY SOLUTIONS LLC
Reel/Frame 075654/0446 →